Sunflower Pharmaceutical Group Co.,Ltd
SZSE:002737.SZ
24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| 1,119.142 | 909.699 | 762.35 | 619.939 | 635.113 | 607.795 | 469.859 | 339.24 | 327.516 | 331.085 | 282.527 | 247.702 | 198.957 |
Depreciation & Amortization
| 183.252 | 268.81 | 167.771 | 149.155 | 149.538 | 144.261 | 144.319 | 134.669 | 91.355 | 72.694 | 64.834 | 56.676 | 47.275 |
Deferred Income Tax
| -4.69 | -8.682 | 1.301 | 15.581 | -2.648 | -9.406 | -21.62 | -22.088 | -6.119 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 24.743 | 15.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -450.63 | 748.706 | -55.014 | 367.472 | 162.896 | 128.254 | -67.617 | -158.475 | -305.75 | -42.942 | -115.869 | -23.534 | -23.764 |
Accounts Receivables
| 77.044 | 26.331 | 38.45 | 332.376 | -57.221 | -79.656 | 55.581 | -117.492 | -133.325 | 67.782 | -99.617 | 0 | 0 |
Inventory
| -241.473 | 73.497 | -152.667 | 101.657 | 130.816 | -20.077 | -150.097 | -120.713 | -43.334 | -8.526 | -15.796 | -47.117 | 62.649 |
Accounts Payables
| -286.2 | 657.561 | 57.901 | -82.143 | 91.949 | 237.393 | 48.519 | 101.818 | -122.973 | 0 | 0 | 0 | 0 |
Other Working Capital
| 25.665 | -8.682 | 1.301 | 15.581 | -2.648 | 148.331 | 82.48 | -37.762 | -262.417 | -34.416 | -100.072 | 23.583 | -86.413 |
Other Non Cash Items
| 893.36 | 37.093 | -9.877 | 33.302 | 33.781 | -14.103 | 12.21 | 25.798 | 12.719 | 42.389 | 61.85 | 46.467 | 35.135 |
Operating Cash Flow
| 923.3 | 1,970.786 | 865.229 | 1,169.867 | 981.328 | 866.207 | 558.771 | 341.231 | 125.84 | 403.225 | 293.342 | 327.31 | 257.603 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -149.165 | -152.9 | -118.313 | -212.731 | -374.236 | -320.867 | -156.884 | -159.49 | -177.316 | -197.711 | -194.439 | -114.218 | -199.097 |
Acquisitions Net
| 4.051 | 3.976 | -1.1 | 309.795 | 385.205 | -16.294 | -41.785 | 0.556 | -96.113 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -2,122.3 | -2,689 | -1,984.12 | -753.39 | -510 | -454 | 190.192 | -260 | -428.677 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 2,270 | 2,193.495 | 1,213.122 | 665.21 | 559.581 | 475.976 | 11.501 | 6.602 | 409.621 | 0.228 | 0.201 | 0.21 | 0.152 |
Other Investing Activites
| 185.364 | 0 | 0.688 | -212.731 | -374.236 | 28.035 | -156.884 | 38.015 | 33.882 | 52.874 | 89.468 | 12.168 | 0.247 |
Investing Cash Flow
| 2.586 | -644.43 | -889.722 | -203.846 | -313.687 | -287.15 | -153.86 | -374.318 | -258.604 | -144.609 | -104.769 | -101.839 | -198.698 |
Financing Activities: | |||||||||||||
Debt Repayment
| -405.567 | -233.569 | -383.49 | -466.38 | -220 | -120.264 | -448.664 | -203.265 | -799.191 | -639.76 | -641.264 | -671.946 | -518.078 |
Common Stock Issued
| 0 | 0 | 0 | 83.571 | 22.765 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | -83.571 | -22.765 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -584 | -406.735 | -201.904 | -582.425 | -584 | -299.526 | -103.744 | -100.58 | -71.471 | -223.261 | -205.943 | -90.833 | -139.326 |
Other Financing Activities
| -42.792 | 408.256 | 286.349 | 276.794 | 393.461 | 168.178 | 157.401 | 308.286 | 149.606 | 1,957.933 | 611.734 | 667.266 | 701.802 |
Financing Cash Flow
| -1,038.83 | -242.01 | -309.326 | -783.599 | -427.816 | -251.612 | -395.007 | 4.442 | -721.056 | 1,094.912 | -235.473 | -95.512 | 44.398 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 0.232 | -0.017 | 0 | 0 | 0.1 | 0.322 | -0.402 | 0.393 | 0 | 0 | 0 | -0 | 0 |
Net Change In Cash
| -111.711 | 1,084.329 | -333.819 | 182.422 | 239.924 | 327.768 | 9.502 | -28.252 | -853.819 | 1,353.528 | -46.9 | 129.959 | 103.303 |
Cash At End Of Period
| 2,287.009 | 2,398.417 | 1,314.088 | 1,647.907 | 1,465.485 | 1,225.561 | 897.793 | 888.29 | 916.542 | 1,770.362 | 416.833 | 463.734 | 333.775 |